143 related articles for article (PubMed ID: 33647567)
1. Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy.
Radchenko V; Engle JW; Thisgaard H
Nucl Med Biol; 2021; 94-95():106. PubMed ID: 33647567
[No Abstract] [Full Text] [Related]
2. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
[TBL] [Abstract][Full Text] [Related]
3. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
4. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
Nelson BJB; Andersson JD; Wuest F
Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
[TBL] [Abstract][Full Text] [Related]
5. 119Sb--a potent Auger emitter for targeted radionuclide therapy.
Thisgaard H; Jensen M
Med Phys; 2008 Sep; 35(9):3839-46. PubMed ID: 18841834
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications.
Bodei L; Kassis AI; Adelstein SJ; Mariani G
Cancer Biother Radiopharm; 2003 Dec; 18(6):861-77. PubMed ID: 14969599
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.
Humm JL; Howell RW; Rao DV
Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
9. Low-energy electron emitters for targeted radiotherapy of small tumours.
Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
[TBL] [Abstract][Full Text] [Related]
10. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
12. Auger-electron spectra of radionuclides for therapy and diagnostics.
Stepanek J; Larsson B; Weinreich R
Acta Oncol; 1996; 35(7):863-8. PubMed ID: 9004764
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo single-cell dosimetry of Auger-electron emitting radionuclides.
Bousis C; Emfietzoglou D; Hadjidoukas P; Nikjoo H
Phys Med Biol; 2010 May; 55(9):2555-72. PubMed ID: 20393237
[TBL] [Abstract][Full Text] [Related]
15. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
Karagiannis TC
Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
[TBL] [Abstract][Full Text] [Related]
16. PARP-targeted Meitner-Auger Electron-emitting Radiopharmaceutical for Radioligand Therapy.
Tan KV
Radiol Imaging Cancer; 2023 Nov; 5(6):e239022. PubMed ID: 37975803
[No Abstract] [Full Text] [Related]
17. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
[TBL] [Abstract][Full Text] [Related]
18. Utility of γH2AX as a molecular marker of DNA double-strand breaks in nuclear medicine: applications to radionuclide therapy employing auger electron-emitting isotopes.
Mah LJ; Orlowski C; Ververis K; El-Osta A; Karagiannis TC
Curr Radiopharm; 2011 Jan; 4(1):59-67. PubMed ID: 22191615
[TBL] [Abstract][Full Text] [Related]
19. Radionuclides in radiation-induced bystander effect; may it share in radionuclide therapy?
Widel M
Neoplasma; 2017; 64(5):641-654. PubMed ID: 28592116
[TBL] [Abstract][Full Text] [Related]
20. Calculation of equivalent dose for Auger electron emitting radionuclides distributed in human organs.
Goddu SM; Howell RW; Rao DV
Acta Oncol; 1996; 35(7):909-16. PubMed ID: 9004771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
